Response to: 'Regarding microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints' by Liebling
Ann Rheum Dis
.
2020 Jun;79(6):e70.
doi: 10.1136/annrheumdis-2019-215509.
Epub 2019 May 2.
Authors
Akihiro Nakamura
1
2
3
4
,
Jason S Rockel
1
2
,
Mohit Kapoor
5
2
6
7
Affiliations
1
Arthritis Program, University Health Network, Toronto, Ontario, Canada.
2
Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, Ontario, Canada.
3
Division of Rheumatology, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
4
Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
5
Arthritis Program, University Health Network, Toronto, Ontario, Canada mkapoor@uhnresearch.ca.
6
Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
7
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
PMID:
31048288
DOI:
10.1136/annrheumdis-2019-215509
No abstract available
Keywords:
knee osteoarthritis; osteoarthritis; treatment.
Publication types
Comment
MeSH terms
Humans
Knee Joint
MicroRNAs*
Oligonucleotides, Antisense
Osteoarthritis*
Substances
MicroRNAs
Oligonucleotides, Antisense